The latest updated of drug registration lists on 03 May 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
21 AMLOD 10 AMLODIPINE BESYLATE 13.868 MG EQ TO AMLODIPINE 10 MG TABLET ALU-PVC/PVDC BLISTERPACK FOR THE TREATMENT OF CHRONIC STABLE ANGINA, OF CONFIRMED OR SUSPECTED VASOSPASTIC ANGINA AND HYPERTENSION. Yes AI KEN PHARMA CO., LTD UNISON LABORATORIES CO., LTD THAILAND CERTIFICATE RELEASED 05 I 4152/16 2023-02-02 2026-02-01 View
22 MXIDINE CHLORHEXIDINE GLUCONATE SOLUTION BP DILUTED TO CHLORHEXIDINE GLUCONATE 0.2% W/V SOLUTION BOTTLE DECREASING THE AMOUNT OF BACTERIA IN THE MOUTH, HELPING TO REDUCE SWELLING AND REDNESS OF THE GUMS AND BLEEDING WHEN YOU BRUSH No ASA LAO SOLE COMPANY LIMITED MERIT ORGANICS LTD INDIA CERTIFICATE RELEASED 01 I 5866/25 2025-01-31 2030-01-30 View
23 PLATOKAM 75 ASPIRIN BP 75 MG ENTERIC COATED TABLET ALU-ALU BLISTER FOR THE SECONDARY PREVENTION OF THROMBOTIC CEREBROVASCULAR OR CARDIOVASCULAR DISEASE AND FOLLOWING BY-PASS SURGERY Yes ASA LAO SOLE COMPANY LIMITED IMPULSE PHARMA PVT. LTD INDIA CERTIFICATE RELEASED 01 I 5867/25 2025-01-31 2030-01-30 View
24 TRANECARE TRANEXAMIC ACID BP 500 MG TABLET ALU-ALU BLISTER USED TO STOP OR REDUCE UNWANTED BLEEDING No ASA LAO SOLE COMPANY LIMITED MERIT ORGANICS LTD INDIA CERTIFICATE RELEASED 01 I 5868/25 2025-01-31 2030-01-30 View
25 VOMICARE DOMPERIDONE BP 10 MG TABLET ALU-ALU BLISTER FOR RELIEF OF THE SYMPTOMS OF NAUSEA AND VOMITING Yes ASA LAO SOLE COMPANY LIMITED MERIT ORGANICS LTD INDIA CERTIFICATE RELEASED 01 I 5869/25 2025-01-31 2030-01-30 View
26 APALIFE 10 ARIPIPRAZOLE 10 MG FILM-COATED TABLETS ALU-ALU SCHIZOPHRENIA IN ADULT AND IN ADOLESCENTS AGED 15 YEARS AND OLDER, MODERATE TO SEVERE MANIC EPISODES IN BIPOLAR 1 DISORDERS AND FOR THE PREVENTION OF A NEW MANIC EPISODE IN ADULT, UP TO 12 WEEKS OF MODERATE TO SEVERE MANIC EPISODE IN BIPOLAR 1 DISORDER No AI KEN PHARMA CO., LTD UNISON LABORATORIES CO., LTD THAILAND CERTIFICATE RELEASED 04 I 4402/18 09-ม.ค.-2025 08-ม.ค.-2030 View
27 APALIFE 15 ARIPIPRAZOLE 15 MG FILM-COATED TABLETS ALU-ALU SCHIZOPHRENIA IN ADULT AND IN ADOLESCENTS AGED 15 YEARS AND OLDER, MODERATE TO SEVERE MANIC EPISODES IN BIPOLAR 1 DISORDERS AND FOR THE PREVENTION OF A NEW MANIC EPISODE IN ADULT, UP TO 12 WEEKS OF MODERATE TO SEVERE MANIC EPISODE IN BIPOLAR 1 DISORDER No AI KEN PHARMA CO., LTD UNISON LABORATORIES CO., LTD THAILAND CERTIFICATE RELEASED 04 I 4403/18 09-ม.ค.-2025 08-ม.ค.-2030 View
28 ATORVIN 10 ATORVASTATIN CALCIUM 10.84 MG EQ.TO ATORVASTATIN 10 MG FILM COATED TABLET ALU-ALU AS AN ADJUNCT TO DIET FOR REDUCTION OF ELEVATED TOTAL CHOLESTEROL (TOTAL -C), LDL-CHOLESTEROL (LDL-C), APOLIPOPROTEIN B AND TRIGLYCERIDE IN ADULTS, ADOLESCENTS AND CHILDREN AGED 10 YEARS OR OLDER WITH PRIMARY HYPERCHOLESTEROLAEMIA OR COMBINED HYPERLIPIDAEMIA WHEN RESPONSE TO DIET AND OTHER NONPHARMACOLOGICAL MEASURES IS INADEQUATE. PREVENTION OF CARDIOVASCULAR EVENTS IN ADULT PATIENTS ESTIMATED TO HAVE A HIGH RISK FOR A FIRST CARDIOVASCULAR EVENT, AS AN ADJUNCT TO CORRECTION OF OTHRT RISK FACTORS Yes AI KEN PHARMA CO., LTD UNISON LABORATORIES CO., LTD THAILAND CERTIFICATE RELEASED 03 I 5424/23 2023-03-31 2026-03-30 View
29 ATORVIN 20 ATORVASTATIN CALCIUM 21.68 MG MG EQ.TO ATORVASTATIN 20 MG FILM COATED TABLET ALU-ALU AS AN ADJUNCT TO DIET FOR REDUCTION OF ELEVATED TOTAL CHOLESTEROL (TOTAL -C), LDL-CHOLESTEROL (LDL-C), APOLIPOPROTEIN B AND TRIGLYCERIDE IN ADULTS, ADOLESCENTS AND CHILDREN AGED 10 YEARS OR OLDER WITH PRIMARY HYPERCHOLESTEROLAEMIA OR COMBINED HYPERLIPIDAEMIA WHEN RESPONSE TO DIET AND OTHER NONPHARMACOLOGICAL MEASURES IS INADEQUATE. PREVENTION OF CARDIOVASCULAR EVENTS IN ADULT PATIENTS ESTIMATED TO HAVE A HIGH RISK FOR A FIRST CARDIOVASCULAR EVENT, AS AN ADJUNCT TO CORRECTION OF OTHRT RISK FACTORS Yes AI KEN PHARMA CO., LTD UNISON LABORATORIES CO., LTD THAILAND CERTIFICATE RELEASED 03 I 5425/23 2023-03-31 2026-03-30 View
30 ATORVIN 40 ATORVASTATIN CALCIUM 43.37 MG MG EQ.TO ATORVASTATIN 40 MG FILM COATED TABLET ALU-ALU AS AN ADJUNCT TO DIET FOR REDUCTION OF ELEVATED TOTAL CHOLESTEROL (TOTAL -C), LDL-CHOLESTEROL (LDL-C), APOLIPOPROTEIN B AND TRIGLYCERIDE IN ADULTS, ADOLESCENTS AND CHILDREN AGED 10 YEARS OR OLDER WITH PRIMARY HYPERCHOLESTEROLAEMIA OR COMBINED HYPERLIPIDAEMIA WHEN RESPONSE TO DIET AND OTHER NONPHARMACOLOGICAL MEASURES IS INADEQUATE. PREVENTION OF CARDIOVASCULAR EVENTS IN ADULT PATIENTS ESTIMATED TO HAVE A HIGH RISK FOR A FIRST CARDIOVASCULAR EVENT, AS AN ADJUNCT TO CORRECTION OF OTHRT RISK FACTORS Yes AI KEN PHARMA CO., LTD UNISON LABORATORIES CO., LTD THAILAND CERTIFICATE RELEASED 03 I 5426/23 2023-03-31 2026-03-30 View